CORRELATION BETWEEN TUMOR VOLUME DOUBLING TIME AND HISTOLOGIC-FINDINGS IN GASTRIC SMOOTH-MUSCLE TUMORS - CLINICAL IMPLICATIONS OF TUMOR VOLUME DOUBLING TIME

被引:11
|
作者
UEYAMA, T
KAWAMOTO, K
IWASHITA, I
MASUDA, K
HARAGUCHI, Y
OIWA, T
YOSHIDA, M
UTSUNOMIYA, T
机构
[1] SAWARA HOSP,DIV GASTROENTEROL,FUKUOKA,JAPAN
[2] OIWA GASTROINTESTINAL HOSP,FUKUOKA,JAPAN
[3] MUNAKATA ISHIKAI HOSP,DIV RADIOL,FUKUOKA,JAPAN
[4] KYUSHU UNIV,FAC MED,DEPT PATHOL 2,FUKUOKA,JAPAN
关键词
X-RAY; GROWTH RATE; MITOTIC RATE; STOMACH; LEIOMYOMA; LEIOMYOSARCOMA;
D O I
10.1002/jso.2930600104
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To assess the clinical implications of the tumor volume doubling time of gastric smooth muscle tumors based on a comparison with the histologic findings, seven tumors (four leiomyomas and three leiomyosarcomas) were followed up by consecutive upper gastrointestinal studies between March 1985 and December 1993. The patients were four men and three women with an average age of 58 years (range: 50-71 years). The observation period ranged from 6 to 51 months, with an average of 35 months. All tumors were surgically resected and the histologic diagnosis was confirmed. The following microscopic features were evaluated: 1) mitotic rate, 2) nuclear atypia, and 3) cellularity. Each tumor was also evaluated for the presence or absence of necrosis, hemorrhage, and degeneration. The doubling time ranged from 5 to 27 months with a mean of 16 months. There was a strong negative correlation between the mitotic rate and the doubling time (r = -0.935, P = 0.0019). The doubling time was also significantly related to nuclear atypia, but the number of tumors studied was so small that its reliability was questionable. The doubling time was not related to any other histologic findings. This study shows that the doubling time is useful for estimating the malignant potential of gastric smooth muscle tumors, and that tumors with a doubling time of 16 months or less should be considered as malignant. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 5 条
  • [1] Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases
    Nakamura, Tomoki
    Matsumine, Akihiko
    Matsubara, Takao
    Asanuma, Kunihiro
    Uchida, Astumasa
    Sudo, Akihiro
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (08) : 819 - 825
  • [2] Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma
    Kim, Jong Kwan
    Kim, Hyung-Don
    Jun, Mi-Jung
    Yun, Sung-Cheol
    Shim, Ju Hyun
    Lee, Han Chu
    Lee, Danbi
    An, Jihyun
    Lim, Young-Suk
    Chung, Young-Hwa
    Lee, Yung Sang
    Kim, Kang Mo
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (10) : 2923 - 2931
  • [3] Natural history of colorectal carcinoma: Can the tumor volume doubling time be predicted by radiologic findings or immunohistochemical variables?
    Iwashita, I
    Ueyama, T
    Iwashita, A
    Kawamoto, K
    Kitagawa, S
    Motooka, M
    Utsunomiya, T
    Masuda, K
    JOURNAL OF SURGICAL ONCOLOGY, 1998, 68 (04) : 215 - 224
  • [4] Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers
    Perez-Morales, Jaileene
    Lu, Hong
    Mu, Wei
    Tunali, Ilke
    Kutuk, Tugce
    Eschrich, Steven A.
    Balagurunathan, Yoganand
    Gillies, Robert J.
    Schabath, Matthew B.
    CANCER BIOMARKERS, 2022, 33 (04) : 489 - 501
  • [5] Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach
    Tosca, E. M.
    Ronchi, D.
    Rocchetti, M.
    Magni, P.
    AAPS JOURNAL, 2024, 26 (05):